Allogene Therapeutics (ALLO) Prepaid Assets (2018 - 2026)

Allogene Therapeutics has disclosed Prepaid Assets across 9 years of filings, most recently posting $6.4 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $6.4 million, down 44.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.4 million (down 44.45% YoY), and the FY2025 annual result was $7.5 million, down 30.9% from the prior year.
• Prepaid Assets came in at $6.4 million for Q1 2026 at Allogene Therapeutics, down from $7.5 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $22.5 million in Q2 2022 to a low of $6.4 million in Q1 2026.
• The 5-year median for Prepaid Assets is $10.5 million (2024), against an average of $11.8 million.
• Across the five-year window, Prepaid Assets plunged 55.01% in 2023 and surged 61.67% in 2024, its largest moves.
• Allogene Therapeutics' Prepaid Assets stood at $11.5 million in 2022, then decreased by 9.44% to $10.4 million in 2023, then gained by 4.72% to $10.9 million in 2024, then plunged by 30.9% to $7.5 million in 2025, then fell by 15.02% to $6.4 million in 2026.
• The last three Prepaid Assets figures came in at $6.4 million (Q1 2026), $7.5 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.